FDA's OTC office
This article was originally published in The Tan Sheet
Office of OTC Drug Evaluation expects to receive seven-to-nine Rx-to-OTC switch applications in 1993, the OTC office's Michael Weintraub, MD, told a June 23 meeting of the National Association of Pharmaceutical Manufacturers. Weintraub predicted that the Nonprescription Drugs Advisory Committee will have more switch meetings scheduled before the end of 1993...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC